DIA 2013 49th Annual Meeting
Click here to go to the previous page
Clinical Trial Visit of the Future: Leveraging Emerging Technologies to Crack the Patient Recruitment Challenge
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 370
Date: Wednesday, June 26, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 157C
CHAIR :
 Komathi Stem, (SCHNON), Senior Director, Product Development, Innovation Lead, Genentech, A Member of the Roche Group, United States
SPEAKER (S):
Marc Foster, Chief Operating Officer, Transparency Life Sciences, United States
Lorenzo Rossaro, MD,FACP (SPKSUP), Chief, Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, United States
 Jonathan S. Helfgott, (SPKAGY), Operations Research Analyst, OSI, OC, CDER, FDA, United States
 Craig H. Lipset, (SPKNON), Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc, United States
Description
This workshop will simulate a future clinical trial visit using emerging technologies followed by an expert panel of regulators, industry leaders, and technology developers discussing the opportunities and challenges.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The Boston Convention and Exhibition Center (BCEC) has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.